Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enno Schmidt

Showing results (171-180 of 348) with videos related to

Pageof 35
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 3, 2025
Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption - A prospective monocenter pilot studyMaike M Holtsche, Nina van Beek, Christoph M Hammers, et al.
International Journal of Dermatology|July 2, 2026
Correlation of Clinical and Histopathological Features With Anti-Desmoglein Antibody Profile in Pemphigus PatientsDipankar De, Debajyoti Chatterjee, Hitaishi Mehta, et al.
Experimental Dermatology|May 14, 2017
Analysis of serum markers of cellular immune activation in patients with bullous pemphigoidKatja Bieber, Anna Lara Ernst, Stefan Tukaj, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 5, 2018
Adjuvante Behandlung des schweren/refraktären bullösen Pemphigoids mit Protein-A-ImmunadsorptionFranziska Hübner, Michael Kasperkiewicz, Diana Knuth-Rehr, et al.
The Journal of Investigative Dermatology|September 14, 2017
The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid AutoantibodiesAnika Kasprick, Maike M Holtsche, Eileen L Rose, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 22, 2025
Differential risks of venous thromboembolic events in pemphigus and pemphigoid diseasesMaren E Buenning, Sri Harini Purusothaman, Svea Symannek, et al.
Frontiers in Medicine|February 28, 2018
IgE-Selective Immunoadsorption for Severe Atopic DermatitisMichael Kasperkiewicz, Sophie-Charlotte Mook, Diana Knuth-Rehr, et al.
The British Journal of Dermatology|November 15, 2025
The role of PKC subtype-specific signaling in the regulation of adhesion in human keratinocytes and skin in pemphigusThomas Schmitt, Julia Haneberg, Desalegn Egu, et al.
Frontiers in Immunology|December 2, 2022
Analysis of T cell repertoires of CD45RO CD4 T cells in cohorts of patients with bullous pemphigoid: A pilot studyMarkus Niebuhr, Farbod Bahreini, Anke Fähnrich, et al.
The Journal of Investigative Dermatology|June 19, 2022
Distinct Metabolite Profile in Pemphigus VulgarisKatharina Boch, Arunabh Sharma, Julica Folberth, et al.
Pageof 35

Showing results (171-180 of 348) with videos related to

Sort By:
Pageof 35
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 3, 2025
Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption - A prospective monocenter pilot studyMaike M Holtsche, Nina van Beek, Christoph M Hammers, et al.
International Journal of Dermatology|July 2, 2026
Correlation of Clinical and Histopathological Features With Anti-Desmoglein Antibody Profile in Pemphigus PatientsDipankar De, Debajyoti Chatterjee, Hitaishi Mehta, et al.
Experimental Dermatology|May 14, 2017
Analysis of serum markers of cellular immune activation in patients with bullous pemphigoidKatja Bieber, Anna Lara Ernst, Stefan Tukaj, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 5, 2018
Adjuvante Behandlung des schweren/refraktären bullösen Pemphigoids mit Protein-A-ImmunadsorptionFranziska Hübner, Michael Kasperkiewicz, Diana Knuth-Rehr, et al.
The Journal of Investigative Dermatology|September 14, 2017
The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid AutoantibodiesAnika Kasprick, Maike M Holtsche, Eileen L Rose, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 22, 2025
Differential risks of venous thromboembolic events in pemphigus and pemphigoid diseasesMaren E Buenning, Sri Harini Purusothaman, Svea Symannek, et al.
Frontiers in Medicine|February 28, 2018
IgE-Selective Immunoadsorption for Severe Atopic DermatitisMichael Kasperkiewicz, Sophie-Charlotte Mook, Diana Knuth-Rehr, et al.
The British Journal of Dermatology|November 15, 2025
The role of PKC subtype-specific signaling in the regulation of adhesion in human keratinocytes and skin in pemphigusThomas Schmitt, Julia Haneberg, Desalegn Egu, et al.
Frontiers in Immunology|December 2, 2022
Analysis of T cell repertoires of CD45RO CD4 T cells in cohorts of patients with bullous pemphigoid: A pilot studyMarkus Niebuhr, Farbod Bahreini, Anke Fähnrich, et al.
The Journal of Investigative Dermatology|June 19, 2022
Distinct Metabolite Profile in Pemphigus VulgarisKatharina Boch, Arunabh Sharma, Julica Folberth, et al.
Pageof 35